Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Therapix Biosciences Ltd (TRPX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 18,410
  • Shares Outstanding, K 3,500
  • Annual Sales, $ 0 K
  • Annual Income, $ -6,240 K
  • 36-Month Beta 1.20
  • Price/Sales N/A
  • Price/Cash Flow 2.75
  • Price/Book 3.37

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.56 +47.75%
on 09/18/18
7.65 -31.24%
on 10/04/18
+1.46 (+38.42%)
since 09/12/18
3-Month
3.00 +75.33%
on 07/16/18
7.65 -31.24%
on 10/04/18
+1.88 (+55.62%)
since 07/12/18
52-Week
3.00 +75.33%
on 07/16/18
7.69 -31.60%
on 04/09/18
-0.55 (-9.47%)
since 10/12/17

Most Recent Stories

More News
Therapix Biosciences, Cannabis Based Drug Candidates Pipeline Review

NEW YORK, NY / ACCESSWIRE / October 5, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive...

TRPX : 5.26 (+5.84%)
Clinical Stage Marijuana Focused Biotech Stocks Trend Higher In August

CORAL GABLES, FL / ACCESSWIRE / August 30, 2018 / Typically the stock market slows down toward the end of summer but this year that has not been the case. The markets are hitting all time highs and one...

TRPX : 5.26 (+5.84%)
INSY : 8.90 (+3.61%)
Therapix Biosciences Announces Positive Data From Recent Pre-clinical Studies for its Drug Candidate THX-160 for Treatment of Pain

Therapix Biosciences Ltd. (NASDAQ: TRPX), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announced today positive results in its pre-clinical...

TRPX : 5.26 (+5.84%)
THXBY : 4.0100 (unch)
Therapix Biosciences Signs Term Sheet for the Transfer of Non-Pain Cannabinoid-Based Drug Pipeline Assets to Cure Pharmaceutical

Therapix Biosciences Ltd. (Nasdaq: TRPX) ("Therapix") a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announced that today that it has signed...

TRPX : 5.26 (+5.84%)
CURR : 2.7000 (+4.45%)
Cure Pharmaceutical Plans to Acquire Cannabinoid-Based Drug Pipeline from Therapix Biosciences Ltd.

CURE Pharmaceutical (OTCQB:CURR), ("CURE"), an innovative drug delivery and development company, announced today that it has signed a term sheet with Therapix Biosciences Ltd. (Nasdaq:TRPX), ("Therapix"),...

TRPX : 5.26 (+5.84%)
CURR : 2.7000 (+4.45%)
Biomica, Evogene's Newly Established Subsidiary, Announces Therapeutic Areas of Focus

Biomica, a subsidiary of Evogene Ltd. (NASDAQ:EVGN) (TASE:EVGN), an emerging biopharmaceutical company developing innovative microbiome-based therapeutics utilizing Evogene's Computational Predictive Biology...

TRPX : 5.26 (+5.84%)
EVGN : 2.92 (-1.02%)
InMed Announces Appointment of Joshua Blacher as Chief Business Officer

TSX: INOTCQB: IMLFF

IMLFF : 0.5628 (-0.79%)
TRPX : 5.26 (+5.84%)
GLMD : 11.64 (+2.37%)
Blog Exposure - Therapix Reported Positive Top-line Results of Phase-IIa Study for Tourette Syndrome Treatment

Stock Monitor: Madrigal Pharma Post Earnings Reporting

TRPX : 5.26 (+5.84%)
Transdermal Drug Delivery Billion Dollar Market Rising Expectations in Resurgent Biotech Sector

MarketNewsUpdates.com News Commentary

MYL : 32.11 (-1.50%)
TRPX : 5.26 (+5.84%)
NTRB : 7.1500 (-4.03%)
BAX : 71.25 (+1.54%)
MNK : 27.16 (+3.78%)
NKTR : 48.91 (+2.11%)
Therapix Biosciences Announces Topline Results of Phase IIa Study at Yale University for Tourette Syndrome Program

TEL AVIV, Israel, April 9, 2018 Therapix Biosciences Ltd. (NASDAQ: TRPX) ("Therapix" or "the Company"), a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics...

TRPX : 5.26 (+5.84%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade TRPX with:

Business Summary

Therapix Biosciences Ltd is a specialty pharmaceutical company. It focuses on developing Cannabinoid technologies in treatment of central nervous system disorders. The company's product pipeline consists of THX-TS01, for the treatment of symptoms related to Tourette Syndrome and THX-ULD01, targeted to...

See More

Key Turning Points

2nd Resistance Point 5.61
1st Resistance Point 5.43
Last Price 5.26
1st Support Level 5.02
2nd Support Level 4.79

See More

52-Week High 7.69
Fibonacci 61.8% 5.90
Fibonacci 50% 5.35
Last Price 5.26
Fibonacci 38.2% 4.79
52-Week Low 3.00

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar